PIL on fake water bottles, medicines: HC seeks Centre's reply

Image
Press Trust of India New Delhi
Last Updated : Jul 31 2015 | 8:57 PM IST
Concerned over risk to public health due to "pervasive menace" of fake water bottles and medicines, the Delhi High Court today sought the Centre's response on a PIL seeking implementation of anti-counterfeit measures like hologram seals and ISI marks.
A bench of Chief Justice G Rohini and Justice Jayant Nath issued notice to the ministries of Health and Consumer Affairs seeking their replies within four weeks and listed the matter for further hearing on September 16.
"Get instructions. It is an important issue which needs consideration. Notice. File your counter in four weeks," the court directed the ministries.
The PIL has alleged that there are about 10,000 illegal bottled water units operating in the National Capital Region (NCR) itself which sell around 30,000-40,000 bottles daily "by refilling used bottles and illegally using labels of 64 licensed and branded manufacturers".
The petition by Satish Chandra, filed through advocate Abhiuday Chandra, has contended that the "Central Pollution Control Board has found that the tap water in Delhi contains carcinogenic substances and the toxic quotient is five times higher than the WHO standards."
"It must be borne in mind that it is primarily these regular sources of water which is used for refilling counterfeit bottled water. Up to 40 per cent of bottled water comes from the same source as tap water," it has said.
It has also said that despite a 2009 order of the high court directing the authorities to take immediate strict action against manufacturers of bottled water operating without obtaining licences, "the problem of spurious water bottling still persists, and on account of this worrying concern the PMO recently in the month of June 2015 has asked states to check water bottling racket".
"Likewise, the problem of counterfeit medicines is taking shape of transnational organised crime in India, affecting health of Indian nationals throughout the country," the plea has said and added that "approximately 25 per cent of drugs in India are counterfeit".
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 31 2015 | 8:57 PM IST

Next Story